VASHTI MILLER: Open Payments
NPI 1295030898 · MOUNT DORA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,846 in 150 payments from 22 companies in 2025. Trend: 2023 $0 · 2024 $403 · 2025 $3,846
Food & beverage: $3,727Education: $119
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 20 | $847 |
| GlaxoSmithKline, LLC. | 28 | $503 |
| Viatris Specialty LLC | 15 | $278 |
| Regeneron Healthcare Solutions, Inc. | 10 | $241 |
| Mallinckrodt Hospital Products Inc. | 11 | $241 |
| Verona Pharma, Inc. | 13 | $212 |
| Actelion Pharmaceuticals US, Inc. | 4 | $209 |
| GENZYME CORPORATION | 5 | $208 |
| Grifols USA, LLC | 2 | $183 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $151 |
Products named: DUPIXENT, FASENRA, NUCALA, YUPELRI, AIRSUPRA, ACTHAR, TEZSPIRE, Ohtuvayre.
Industry payments across FL — which companies pay providers there.
